Translate this page into:
ORIGINAL CONTRIBUTION
PMID: 28134173
Evaluation Of-astemizole- A New H-1 Blocking Antihistamine in Urticaria
JS Pasricha, Anil Dashore, RK Arya
,
Correspondence Address:
Correspondence Address:
| How to cite this article: Pasricha J S, Dashore A, Arya R K. Evaluation Of-astemizole- A New H-1 Blocking Antihistamine in Urticaria. Indian J Dermatol Venereol Leprol 1988;54:27-29 |
Copyright: (C)1988 Indian Journal of Dermatology, Venereology, and Leprology
Abstract
An open trial of astemizole a new anthistamine on 30 patients, having urticaria revealed complete relief in 28 patients. The controlling daily dose was 10 mg in 17 patients, 20 mg in 7 and 30 mg in 4. Two patients did not improve even with 40 mg a day given for 7 days. The side effects included mild sedation in 7, dryness of mouth in 3 and constipation in 2 on a dose of 20 or 30 mg a day. Laboratory parameters remained almost normal.Fulltext Views
1,245
PDF downloads
599
